Strata Skin Sciences Return on Tangible Equity 2010-2024 | SSKN

Current and historical return on tangible equity values for Strata Skin Sciences (SSKN) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Strata Skin Sciences Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $-0.01B $-0.00B 327.27%
2024-06-30 $-0.01B $-0.00B 320.00%
2024-03-31 $-0.01B $-0.00B 293.33%
2023-12-31 $-0.01B $-0.00B 258.82%
2023-09-30 $-0.01B $-0.00B 140.00%
2023-06-30 $-0.01B $-0.01B 121.74%
2023-03-31 $-0.01B $-0.01B 120.00%
2022-12-31 $-0.01B $-0.00B 126.32%
2022-09-30 $-0.01B $-0.01B 350.00%
2022-06-30 $-0.01B $-0.01B -700.00%
2022-03-31 $-0.00B $-0.01B -80.00%
2021-12-31 $-0.00B $0.01B -35.29%
2021-09-30 $-0.00B $0.01B -21.05%
2021-06-30 $-0.00B $0.01B -19.51%
2021-03-31 $-0.01B $0.01B -48.78%
2020-12-31 $-0.00B $0.01B -36.36%
2020-09-30 $-0.01B $0.01B -44.44%
2020-06-30 $-0.01B $0.01B -42.55%
2020-03-31 $-0.00B $0.01B -33.33%
2019-12-31 $-0.00B $0.01B -33.33%
2019-09-30 $-0.00B $0.01B -24.49%
2019-06-30 $-0.00B $0.01B -23.08%
2019-03-31 $-0.00B $0.01B -22.22%
2018-12-31 $-0.00B $0.01B -38.10%
2018-09-30 $-0.01B $0.02B -114.29%
2018-06-30 $-0.02B $0.01B -525.00%
2018-03-31 $-0.02B $0.00B 1050.00%
2017-12-31 $-0.02B $-0.00B 466.67%
2017-09-30 $-0.02B $0.00B 300.00%
2017-06-30 $-0.01B $-0.01B 70.59%
2017-03-31 $-0.01B $-0.01B 66.67%
2016-12-31 $-0.00B $-0.01B 55.17%
2016-09-30 $-0.00B $-0.01B 53.33%
2016-06-30 $-0.01B $-0.01B 175.00%
2016-03-31 $-0.02B $-0.01B 366.67%
2015-12-31 $-0.03B $-0.01B 1600.00%
2015-09-30 $-0.03B $-0.01B -1015.38%
2015-06-30 $-0.02B $0.00B -248.65%
2015-03-31 $-0.01B $0.01B -133.33%
2014-12-31 $-0.02B $0.01B -150.00%
2014-09-30 $-0.01B $0.02B -155.56%
2014-06-30 $-0.02B $0.01B -245.16%
2014-03-31 $-0.03B $0.01B -263.41%
2013-12-31 $-0.03B $0.01B -179.31%
2013-09-30 $-0.03B $0.01B -168.75%
2013-06-30 $-0.03B $0.02B -138.89%
2013-03-31 $-0.02B $0.02B -124.32%
2012-12-31 $-0.02B $0.01B -117.33%
2012-09-30 $-0.02B $0.02B -92.31%
2012-06-30 $-0.02B $0.02B -95.65%
2012-03-31 $-0.02B $0.02B -91.67%
2011-12-31 $-0.02B $0.03B -84.85%
2011-09-30 $-0.02B $0.02B -83.17%
2011-06-30 $-0.02B $0.02B -67.23%
2011-03-31 $-0.02B $0.03B -65.57%
2010-12-31 $-0.02B $0.03B -63.49%
2010-09-30 $-0.02B $0.04B -67.74%
2010-06-30 $-0.02B $0.03B -75.00%
2010-03-31 $-0.02B $0.03B -85.11%
2009-12-31 $-0.02B $0.03B -102.70%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.011B $0.033B
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.872B 57.28
Tempus AI (TEM) United States $10.232B 0.00
Hims & Hers Health (HIMS) United States $8.842B 224.83
Inspire Medical Systems (INSP) United States $5.430B 169.35
IRhythm Technologies (IRTC) United States $3.397B 0.00
Privia Health (PRVA) United States $2.723B 226.90
Enovis (ENOV) United States $2.544B 16.95
Azenta (AZTA) United States $2.469B 114.98
Clover Health Investments (CLOV) United States $2.225B 0.00
Schrodinger (SDGR) United States $1.886B 0.00
Omnicell (OMCL) United States $1.826B 39.83
10x Genomics (TXG) United States $1.773B 0.00
Phreesia (PHR) United States $1.680B 0.00
Butterfly Network (BFLY) United States $0.937B 0.00
Talkspace (TALK) United States $0.608B 0.00
Standard BioTools (LAB) United States $0.529B 0.00
Fulgent Genetics (FLGT) United States $0.507B 0.00
TruBridge (TBRG) United States $0.380B 110.57
Nyxoah SA (NYXH) Belgium $0.369B 0.00
Health Catalyst (HCAT) United States $0.334B 0.00
Pulmonx (LUNG) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.233B 0.00
American Well (AMWL) United States $0.176B 0.00
EUDA Health Holdings (EUDA) Singapore $0.104B 0.00
MDxHealth SA (MDXH) Belgium $0.087B 0.00
P3 Health Partners (PIII) United States $0.073B 0.00
CareCloud (CCLD) United States $0.066B 0.00
HeartBeam (BEAT) United States $0.065B 0.00
111 (YI) China $0.057B 0.00
Zepp Health (ZEPP) China $0.045B 0.00
Outset Medical (OM) United States $0.043B 0.00
SHL Telemedicine (SHLT) Israel $0.043B 0.00
Zhongchao (ZCMD) China $0.037B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
MSP Recovery (MSPR) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.016B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00